Screenshot 2019-03-29 at 00.21.18.png
Screenshot 2019-03-29 at 00.20.23.png
Screenshot 2019-03-29 at 00.20.02.png
Screenshot 2019-03-29 at 00.27.15.png
Screenshot 2019-03-29 at 00.29.52.png
Screenshot 2019-03-29 at 00.28.47.png
Screenshot 2019-03-29 at 00.27.40.png

The Anser Clavicle Pin project started with a concept and a sketch on a piece of paper.

In cooperation with prof.dr A van Kampen and N Verdonschot from the Orthopaedic Surgery department at the Radboud University Medical Center (Nijmegen, the Netherlands) an initial prototype was developed together with BAAT Medical BV (Hengelo (ov), Netherlands).

Once the concept in an in-vitro setting proved to be viable and feasible, a collaboration between Isshoni BV (Paul Hoogervorst, Orthopedic Surgeon),  Evolve Medical BV and the Radboud University Medical Center was initiated. 

Patent protection by means of a PCT procedure has resulted in multiple patents including the USA, CN and EU.

Isshoni BV was awarded an MKB Innovation and Technology Fund, a Stichting Technologie en Wetenschap (STW) Valorisation grant and a STW Take-off loan. Formal investors have backed the project.


Evolve Medical BV has been developed by BAAT Medical BV and coordinates the different necessary disciplines such as medical, engineering & commercial right from the start.

In July 2020 the Anser Clavicle Pin has obtained CE certification.


In August 2020 the Anser Clavicle Pin has been FDA approved.

The 1-year follow up results of the first case series of 20 patients treated with the Anser Clavicle Pin has been reviewed and published in the Journal of Shoulder and Elbow Surgery International in 2020.